Janney Montgomery Scott’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$334M Buy
1,366,010
+75,420
+6% +$17.6M 0.83% 15
2025
Q4
$267M Sell
1,290,590
-30,442
-2% -$6.02M 0.61% 27
2025
Q3
$245M Buy
1,321,032
+27,926
+2% +$4.78M 0.58% 28
2025
Q2
$198M Sell
1,293,106
-50,034
-4% -$7.69M 0.52% 34
2025
Q1
$223M Buy
1,343,140
+50,353
+4% +$7.88M 0.63% 28
2024
Q4
$187M Buy
1,292,787
+120,815
+10% +$18.7M 0.52% 34
2024
Q3
$190M Buy
1,171,972
+19,874
+2% +$3.17M 0.53% 35
2024
Q2
$168M Sell
1,152,098
-57,687
-5% -$8.58M 0.51% 34
2024
Q1
$191M Sell
1,209,785
-21,871
-2% -$3.48M 0.57% 28
2023
Q4
$193M Buy
+1,231,656
New +$189M 0.63% 25
2023
Q3
Sell
-1,302,701
Closed -$216M 2679
2023
Q2
$216M Sell
1,302,701
-19,921
-2% -$3.22M 0.75% 19
2023
Q1
$205M Buy
1,322,622
+73,292
+6% +$11.8M 0.84% 14
2022
Q4
$221M Buy
1,249,330
+24,249
+2% +$4.19M 0.86% 13
2022
Q3
$200M Buy
1,225,081
+24,630
+2% +$4.17M 0.86% 15
2022
Q2
$213M Buy
1,200,451
+25,191
+2% +$4.49M 0.96% 12
2022
Q1
$208M Buy
1,175,260
+21,400
+2% +$3.64M 0.89% 16
2021
Q4
$197M Buy
1,153,860
+78,856
+7% +$12.9M 0.77% 20
2021
Q3
$174M Buy
1,075,004
+41,523
+4% +$7.08M 0.74% 20
2021
Q2
$170M Sell
1,033,481
-17,831
-2% -$2.95M 0.75% 20
2021
Q1
$173M Sell
1,051,312
-33,609
-3% -$5.44M 0.84% 16
2020
Q4
$171M Buy
1,084,921
+40,511
+4% +$5.98M 0.82% 19
2020
Q3
$155M Buy
1,044,410
+32,656
+3% +$4.83M 0.89% 16
2020
Q2
$142M Buy
1,011,754
+42,041
+4% +$6.13M 0.9% 13
2020
Q1
$127M Buy
969,713
+47,913
+5% +$6.8M 1.01% 11
2019
Q4
$134M Buy
921,800
+27,149
+3% +$3.68M 0.88% 15
2019
Q3
$116M Buy
894,651
+32,924
+4% +$4.34M 0.84% 14
2019
Q2
$120M Buy
861,727
+37,473
+5% +$5.19M 0.92% 11
2019
Q1
$115M Sell
824,254
-17,900
-2% -$2.4M 0.95% 10
2018
Q4
$109M Sell
842,154
-58,088
-6% -$8.1M 1.05% 9
2018
Q3
$124M Buy
900,242
+25,008
+3% +$3.32M 1.07% 8
2018
Q2
$106M Buy
875,234
+38,201
+5% +$4.77M 1.02% 9
2018
Q1
$107M Buy
837,033
+40,610
+5% +$5.49M 1.08% 9
2017
Q4
$111M Buy
796,423
+12,477
+2% +$1.74M 1.16% 7
2017
Q3
$102M Buy
783,946
+12,078
+2% +$1.6M 1.16% 7
2017
Q2
$102M Buy
771,868
+3,533
+0.5% +$451K 1.28% 6
2017
Q1
$95.7M Buy
768,335
+86,458
+13% +$10.3M 1.27% 5
2016
Q4
$78.6M Buy
681,877
+47,953
+8% +$5.54M 1.18% 7
2016
Q3
$74.9M Sell
633,924
-559,722
-47% -$67.9M 1.32% 6
2016
Q2
$145M Buy
1,193,646
+666,009
+126% +$75.7M 2.95% 3
2016
Q1
$57.1M Buy
527,637
+45,451
+9% +$4.71M 1.5% 6
2015
Q4
$49.5M Buy
482,186
+14,001
+3% +$1.41M 1.28% 7
2015
Q3
$43.7M Buy
468,185
+3,943
+0.8% +$381K 1.23% 3
2015
Q2
$45.2M Buy
464,242
+30,991
+7% +$3.1M 0.95% 3
2015
Q1
$43.6M Buy
433,251
+21,548
+5% +$2.19M 0.81% 5
2014
Q4
$43.1M Buy
411,703
+14,864
+4% +$1.57M 0.86% 6
2014
Q3
$42.3M Buy
396,839
+17,311
+5% +$1.8M 0.88% 6
2014
Q2
$39.7M Buy
379,528
+21,746
+6% +$2.2M 0.87% 7
2014
Q1
$35.1M Buy
357,782
+24,973
+8% +$2.32M 0.85% 7
2013
Q4
$30.5M Buy
332,809
+4,517
+1% +$416K 0.81% 7
2013
Q3
$28.5M Buy
328,292
+209,789
+177% +$18.8M 0.85% 7
2013
Q2
$10.2M Buy
+118,503
New +$10.1M 1.06% 11

Other funds holding JNJ

Janney Montgomery Scott's JNJ Position: Q1 2026 in Review

Janney Montgomery Scott increased its Johnson & Johnson (JNJ) stake by 5.8% in Q1 2026, buying an estimated $17.6M and bringing the position to 1,366,010 shares worth $334M. The position accounts for 0.83% of the portfolio, ranked #15.

Janney Montgomery Scott first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Janney Montgomery Scott held 1,366,010 shares of Johnson & Johnson worth $334M as of Q1 2026.
  • Janney Montgomery Scott bought 75,420 Johnson & Johnson shares in Q1 2026, an estimated $17.6M.
  • Johnson & Johnson made up 0.83% of Janney Montgomery Scott's portfolio in Q1 2026, its #15 holding.
  • Janney Montgomery Scott first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.